Both in Pharmaceuticals
Tilray Brands vs Aquestive Therapeutics
Over the past year TLRY returned −78.6% and AQST returned −17.3%; their daily moves had a correlation of 0.09.
TLRY −78.6% AQST −17.3%Growth of $1, one year, split-adjusted
| Metric | TLRY | AQST |
|---|---|---|
| Price | $3.95 | $4.67 |
| Market cap | $583.7M | $586.1M |
| Today | −1.74% | −1.68% |
| 1 month | −13.9% | −7.0% |
| 6 months | −34.1% | +15.6% |
| Year to date | −56.3% | −27.7% |
| 1 year | −65.7% | −22.0% |
| Revenue growth (YoY) | +25.5% | +38.1% |
| Gross margin | 32.1% | 70.9% |
| Net margin | −17.6% | −165.5% |
| P/E (TTM) | — | — |
| Price / sales | 0.6× | 10.8× |
| Net cash | $83.9M | $47.8M |
| Dividend yield | — | — |
| Volatility (60d) | 46.2% | 48.4% |
| Short % of float | 14.4% | 25.2% |
| Next earnings | Oct 8, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).